A clinical formulation indicated for Women's Health. This product supports blood flow to specific peripheral regions to optimize physiological response and physical comfort.
A PDE5 inhibitor utilized to manage female sexual arousal concerns by designed to support blood flow to target improved arousal and sexual satisfaction.
Mechanism of Action
It works by increasing blood flow to the genital area. By inhibiting the PDE5 enzyme, it promotes the relaxation of smooth muscle and enhances sensitivity during stimulation.
Route of Administration
Oral
Onset Time
30–60 minutes
Duration
4–6 hours
Contraindications
Concurrent use of nitrates, Severe heart disease, Uncontrolled hypertension, Allergy to sildenafil
Information for Lovegra is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.